eight, I agree with your positive sentiment on CMP but you are off the mark on a few things in your post.
The very simple thesis is the core business is improving and the backlog of orders is being reduced, with support from falling AUD. Confirmation of this in the interim result will make it cheap and warrant a re-rate. e-Health division is exciting but is at least another 12 months off becoming a significant contributor to revenue, and the success of this division will depend on the ability of CMP to raise capital to fully capture the opportunity at hand, which in turn requires confirmation of improving core business and a share price re-rate, so it all comes down to that.
Don't have too high expectations for Driver Vigilance, treatment, etc. They are valuable technologies but they are not first priority at this stage and if they are eventually monetised the most likely strategy is through license to a larger player.
It won't be another RMD, but it can be a $100m company within 12 months if they execute on both the operational performance of the business and their communication of the story/strategy to the market.
CMP Price at posting:
11.5¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)